US Stock MarketDetailed Quotes

MYGN Myriad Genetics

Watchlist
  • 16.690
  • +0.420+2.58%
Close Dec 2 16:00 ET
  • 16.550
  • -0.140-0.84%
Post 20:01 ET
1.52BMarket Cap-13039P/E (TTM)

Myriad Genetics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Myriad Genetics Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
210.79M
213.30M
+2.51M
Beat Est.
+9.85%
+11.15%
+1.19%
EPS
-0.23
-0.24
-0.01
Miss Est.
+69.88%
+68.00%
-6.24%
Analyst Rating
Hold

Nov 30, 2024

Myriad Genetics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 213.440M --
Feb 24, 2022 2021/Q4 -- / 173.435M --
Nov 7, 2024 2024/Q3 213.300M / 210.794M --
Aug 6, 2024 2024/Q2 211.500M / 205.006M --
May 7, 2024 2024/Q1 202.200M / 193.251M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 213.440M--
Feb 24, 20222021/Q4-- / 173.435M--
Nov 7, 20242024/Q3213.300M / 210.794M--
Aug 6, 20242024/Q2211.500M / 205.006M--
May 7, 20242024/Q1202.200M / 193.251M--

Unlock Free Earnings Estimates

Myriad Genetics Earnings Reports

  • Myriad Genetics | 10-Q: Q3 2024 Earnings Report

    Nov 8 21:19

  • Myriad Genetics | 10-Q: Q2 2024 Earnings Report

    Aug 7 20:26

  • Myriad Genetics | 8-K: Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%

    Aug 7 04:18

  • Myriad Genetics | 10-Q: Q1 2024 Earnings Report

    May 8 20:18

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Hold

    • Buy

      33.33%

    • Hold

      44.44%

    • Sell

      22.22%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data